Iolyx Therapeutics
PrivateLast Round
Series B
Dec 3, 2025
Total Funding Raised
$45M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Iolyx Therapeutics is a biotechnology company that develops targeted immunomodulatory therapies for ocular inflammatory and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Iolyx Therapeutics Comparables
Compare Iolyx Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stuart Therapeutics, Inc. | 87% | |
| TearSolutions | 87% | |
| Selagine, Inc. | 83% |
Iolyx Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 3, 2025 | ||||
| Series A | Apr 20, 2023 |
Iolyx Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Frazier Healthcare Partners | Series A |
| Frazier Life Sciences | Series B |
| Cooley | Series B |
| Alumni Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 68% MoM.
- Dec 3, 2025
$15M round completed.
Iolyx Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Iolyx Therapeutics's valuation, stock price, and market status.
Is Iolyx Therapeutics a public or private company?
Iolyx Therapeutics is a private company.
What is the current stock price of Iolyx Therapeutics?
Iolyx Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Iolyx Therapeutics worth (valuation)?
Valuation information for Iolyx Therapeutics is not publicly available.
Can I buy Iolyx Therapeutics stock?
Iolyx Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Iolyx Therapeutics's last funding round?
Iolyx Therapeutics's most recent funding round was Series B on December 3, 2025.
Who are the main investors in Iolyx Therapeutics?
Key investors in Iolyx Therapeutics include Frazier Life Sciences.
Will Iolyx Therapeutics IPO soon?
No public IPO plans have been announced for Iolyx Therapeutics.
How can I track Iolyx Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Iolyx Therapeutics's secondary market activity and sign up for updates.